Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing P Sharma, JR Klemp, BF Kimler, JD Mahnken, LJ Geier, QJ Khan, M Elia, ... Breast cancer research and treatment 145, 707-714, 2014 | 206 | 2014 |
Efficacy of neoadjuvant carboplatin plus docetaxel in triple-negative breast cancer: combined analysis of two cohorts P Sharma, S López-Tarruella, JA García-Saenz, C Ward, CS Connor, ... Clinical cancer research 23 (3), 649-657, 2017 | 139 | 2017 |
Characterization of the naive murine antibody repertoire using unamplified high-throughput sequencing TA Rettig, C Ward, BA Bye, MJ Pecaut, SK Chapes PloS one 13 (1), e0190982, 2018 | 44 | 2018 |
Effects of spaceflight on the immunoglobulin repertoire of unimmunized C57BL/6 mice C Ward, TA Rettig, S Hlavacek, BA Bye, MJ Pecaut, SK Chapes Life Sciences in Space Research 16, 63-75, 2018 | 36 | 2018 |
Validation of methods to assess the immunoglobulin gene repertoire in tissues obtained from mice on the international space station TA Rettig, C Ward, MJ Pecaut, SK Chapes Gravitational and Space Research 5 (1), 2-23, 2017 | 12 | 2017 |
Prognosis of triple negative breast cancer patients who attain pathological complete response with neoadjuvant carboplatin/docetaxel and do not receive adjuvant anthracycline … P Sharma, BF Kimler, C Ward, A O'Dea, MS Hoffmann, JR Klemp, ... Journal of Clinical Oncology 34 (15_suppl), 1015-1015, 2016 | 12 | 2016 |
Effects of skeletal unloading on the antibody repertoire of tetanus toxoid and/or CpG treated C57BL/6J mice TA Rettig, BA Bye, NC Nishiyama, S Hlavacek, C Ward, MJ Pecaut, ... PloS one 14 (1), e0210284, 2019 | 11 | 2019 |
Impact of neoadjuvant chemotherapy on axillary nodal involvement in patients with clinically node negative triple negative breast cancer CS Connor, BF Kimler, JMV Mammen, MK McGinness, JL Wagner, ... Journal of surgical oncology 111 (2), 198-202, 2015 | 10 | 2015 |
Outcomes with neoadjuvant versus adjuvant chemotherapy for T1-2 node negative triple negative breast cancer. P Sharma, BF Kimler, JR Klemp, C Ward, CS Connor, M McGinness, ... Journal of Clinical Oncology 33 (15_suppl), 1092-1092, 2015 | 6 | 2015 |
Chemotherapy-induced amenorrhea (CIA) risk associated with taxane/platinum-based chemotherapy in young (≤ 45 years) breast cancer patients. P Sharma, L Rock, BF Kimler, QJ Khan, CS Connor, M McGinness, ... Journal of Clinical Oncology 32 (15_suppl), 9592-9592, 2014 | 4 | 2014 |
Abstract P5-14-06: Lapatinib reverses endocrine resistance in select patients with HER2 negative, hormone positive metastatic breast cancer P Sharma, BF Kimler, C Ward, K Wang, S Ali, S Balasubramanian, ... Cancer Research 76 (4_Supplement), P5-14-06-P5-14-06, 2016 | 1 | 2016 |
Abstract P3-06-16: Thrombocytopenia is associated with pathological complete response to neoadjuvant carboplatin/docetaxel chemotherapy in BRCA wild type … P Sharma, BC Powers, BF Kimler, C Ward, JR Klemp, CS Connor, ... Cancer Research 75 (9_Supplement), P3-06-16-P3-06-16, 2015 | 1 | 2015 |
Characterization of the naïve kappa light chain murine immunoglobulin repertoire in spaceflight C Ward Kansas State University, 2017 | | 2017 |
Thrombocytopenia is associated with pathological complete response to neoadjuvant carboplatin/docetaxel chemotherapy in BRCA wild type triple negative breast cancer P Sharma, BC Powers, BF Kimler, C Ward, JR Klemp, CS Connor, ... CANCER RESEARCH 75 (9), 2015 | | 2015 |
Impact of Neoadjuvant Chemotherapy on Extent of Axillary Surgery in Patients With Triple-Negative Breast Cancer CS Connor, B Kimler, JM Mammen, MK McGinness, JL Wagner, SM Alsop, ... ANNALS OF SURGICAL ONCOLOGY 21, 38-39, 2014 | | 2014 |